Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis

  Free Subscription


05.03.2018

1 Am J Gastroenterol
1 BMC Cancer
2 Cancer
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
6 Gut
1 Hepatology
1 Int J STD AIDS
1 J Hepatol
1 J Infect Dis
3 J Med Virol
7 J Viral Hepat
1 J Virol
2 JAMA
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. YI W, Pan CQ, Li MH, Wan G, et al
    The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0010.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. FAIRMAN J, Liu KH, Menne S
    Prevention of liver tumor formation in woodchucks with established hepatocellular carcinoma by treatment with cationic liposome-DNA complexes.
    BMC Cancer. 2017;17:172.
    PubMed     Text format     Abstract available


    Cancer

  3. KANTARJIAN HM, Paul S
    Hepatitis C: When high drug prices preclude patient benefit.
    Cancer. 2018 Feb 27. doi: 10.1002/cncr.31292.
    PubMed     Text format    

  4. SORIANO V, Tefferi A
    Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
    Cancer. 2018 Feb 27. doi: 10.1002/cncr.31291.
    PubMed     Text format    


    Dig Dis Sci

  5. TANEJA S, Duseja A, De A, Mehta M, et al
    Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4979.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  6. PYRSOPOULOS N, Trilianos P, Lingiah VA, Fung P, et al
    The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data.
    Eur J Gastroenterol Hepatol. 2018 Feb 23. doi: 10.1097/MEG.0000000000001101.
    PubMed     Text format     Abstract available


    Gut

  7. SCHIAVON LL, Narciso-Schiavon JL, Ferraz MLG, Silva AEB, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up?
    Gut. 2017;66:1169-1170.
    PubMed     Text format    

  8. DAHEIM M, Lang S, Goeser T, Steffen HM, et al
    Real-world risk score for hepatocellular carcinoma risk prediction in CHBV: a validation outside of Asia.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312993. doi: 10.1136/gutjnl-2016-312993.
    PubMed     Text format    

  9. RAMACHANDRAN A, Jaeschke H
    PGAM5: a new player in immune-mediated liver injury.
    Gut. 2017;66:567-568.
    PubMed     Text format    

  10. TSENG TC, Yang HC, Kao JH
    More viral mutants, less HBsAg clearance? One size may not fit all.
    Gut. 2017;66:1349.
    PubMed     Text format    

  11. THOMPSON A, Locarnini S, Revill P
    Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'.
    Gut. 2017;66:1534-1535.
    PubMed     Text format    

  12. LEMOINE M, Thursz M, Mallet V, Shimakawa Y, et al
    Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference.
    Gut. 2017;66:195-196.
    PubMed     Text format    


    Hepatology

  13. FOSTER GR, Agarwal K, Cramp ME, Moreea S, et al
    Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial.
    Hepatology. 2018 Feb 23. doi: 10.1002/hep.29852.
    PubMed     Text format     Abstract available


    Int J STD AIDS

  14. ALVAREZ H, Marino A, Valcarce N, Khoo S, et al
    Cure of chronic hepatitis C virus infection in an HIV-coinfected patient with multiple comorbidities and drug interaction challenges.
    Int J STD AIDS. 2018 Jan 1:956462418755537. doi: 10.1177/0956462418755537.
    PubMed     Text format     Abstract available


    J Hepatol

  15. CRESPO G, Trota N, Londono MC, Mauro E, et al
    The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in wait-list composition.
    J Hepatol. 2018 Feb 23. pii: S0168-8278(18)30129.
    PubMed     Text format     Abstract available


    J Infect Dis

  16. ZIMMER CL, Rinker F, Honer Zu Siederdissen C, Manns MP, et al
    Increased NK Cell Function after Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Associates with Liver Damage and HBsAg Loss.
    J Infect Dis. 2018 Feb 17. pii: 4868650. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  17. COLOMBATTO P, Barbera C, Bortolotti F, Maina AM, et al
    HBV Pre-Core mutant in genotype-D infected children is selected during HBeAg/anti-HBe seroconversion and leads to HBeAg negative chronic hepatitis B in adulthood.
    J Med Virol. 2018 Feb 28. doi: 10.1002/jmv.25068.
    PubMed     Text format     Abstract available

  18. CORDIE A, Salama A, El-Sharkawy M, El-Nahaas SM, et al
    Comparing the efficiency of Fib-4, Egy-score, APRI and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    J Med Virol. 2018 Feb 24. doi: 10.1002/jmv.25064.
    PubMed     Text format     Abstract available

  19. SHOUSHA HI, Abdelaziz RA, Azab SM, Khairy M, et al
    Effect of Treatment with Direct Acting Antivirals on Body Mass Index and Hepatic Steatosis in Chronic Hepatitis C.
    J Med Virol. 2018 Feb 22. doi: 10.1002/jmv.25062.
    PubMed     Text format     Abstract available


    J Viral Hepat

  20. CACOUB P, Buggisch P, Carrion JA, S Cooke G, et al
    Direct Medical Costs Associated with the Extrahepatic Manifestations of Hepatitis C Infection in Europe.
    J Viral Hepat. 2018 Feb 24. doi: 10.1111/jvh.12881.
    PubMed     Text format     Abstract available

  21. LI J, Zhang T, Gordon SC, Rupp LB, et al
    Impact of sustained virological response on risk of type 2 diabetes among hepatitis C patients in the US.
    J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12887.
    PubMed     Text format     Abstract available

  22. CHEN JY, Ren Y, Yan P, Belina ME, et al
    Tricyclic Antidepressant Use and the Risk of Fibrosis Progression in Hepatitis C-Infected Persons: Results from ERCHIVES.
    J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12884.
    PubMed     Text format     Abstract available

  23. MACLEAN CD, Berger C, Cangiano ML, Ziegelman D, et al
    Impact of Electronic Reminder Systems on Hepatitis C Screening in Primary Care.
    J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12885.
    PubMed     Text format     Abstract available

  24. DUARTE G, Williams CJ, Vasconcelos P, Nogueira P, et al
    Capacity to report on mortality attributable to chronic Hepatitis B and C infections by Member States: an exercise to monitor progress toward viral hepatitis elimination.
    J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12882.
    PubMed     Text format     Abstract available

  25. YOUNOSSI ZM, Tanaka A, Eguchi Y, Henry L, et al
    Treatment of Hepatitis C Virus Leads to Economic Gains Related to Reduction in Cases of Hepatocellular Carcinoma and Decompensated Cirrhosis in Japan.
    J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12886.
    PubMed     Text format     Abstract available

  26. OLVEIRA A, Dominguez L, Troya J, Arias A, et al
    Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals.
    J Viral Hepat. 2018 Feb 24. doi: 10.1111/jvh.12883.
    PubMed     Text format     Abstract available


    J Virol

  27. GU J, Hardy J, Boo I, Vietheer P, et al
    Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
    J Virol. 2018 Feb 21. pii: JVI.02066-17. doi: 10.1128/JVI.02066.
    PubMed     Text format     Abstract available


    JAMA


  28. A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B).
    JAMA. 2018;319:822-823.
    PubMed     Text format    

  29. KUEHN BM
    Hepatitis B Recommendations Updated.
    JAMA. 2018;319:762.
    PubMed     Text format    


    Lancet Infect Dis

  30. DEBES JD, Singh D
    Beyond one virus: vaccination against hepatitis B after hepatitis C treatment.
    Lancet Infect Dis. 2018;18:246-247.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep

  31. COMER M, Matthias J, Nicholson G, Asher A, et al
    Notes from the Field: Increase in Acute Hepatitis B Infections - Pasco County, Florida, 2011-2016.
    MMWR Morb Mortal Wkly Rep. 2018;67:230-231.
    PubMed     Text format    


    PLoS One

  32. CHENG PN, Chiu YC, Chiu HC, Chien SC, et al
    The characteristics of residents with unawareness of hepatitis C virus infection in community.
    PLoS One. 2018;13:e0193251.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: